• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Daptomycin-resistant Enteroccoccus faecium in a patient with no prior exposure to daptomycin.

作者信息

Fraher M H, Corcoran G D, Creagh S, Feeney E

出版信息

J Hosp Infect. 2007 Apr;65(4):376-8. doi: 10.1016/j.jhin.2007.01.002. Epub 2007 Feb 20.

DOI:10.1016/j.jhin.2007.01.002
PMID:17316896
Abstract
摘要

相似文献

1
Daptomycin-resistant Enteroccoccus faecium in a patient with no prior exposure to daptomycin.一名未曾接触过达托霉素的患者体内出现对达托霉素耐药的屎肠球菌。
J Hosp Infect. 2007 Apr;65(4):376-8. doi: 10.1016/j.jhin.2007.01.002. Epub 2007 Feb 20.
2
Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy.在达托霉素治疗期间粪肠球菌中出现达托霉素耐药性。
Antimicrob Agents Chemother. 2005 Apr;49(4):1664-5. doi: 10.1128/AAC.49.4.1664-1665.2005.
3
In vitro activities of tigecycline, daptomycin, linezolid and quinupristin/dalfopristin against glycopeptide-resistant Enterococcus faecium.替加环素、达托霉素、利奈唑胺和奎奴普丁/达福普汀对耐糖肽粪肠球菌的体外活性。
Int J Antimicrob Agents. 2007 Mar;29(3):358-60. doi: 10.1016/j.ijantimicag.2006.10.007. Epub 2007 Jan 16.
4
In vitro activity of daptomycin against isolates of Staphylococcus aureus and enterococci: first results from Turkey.达托霉素对金黄色葡萄球菌和肠球菌分离株的体外活性：来自土耳其的初步结果。
Int J Antimicrob Agents. 2004 Jun;23(6):642-3. doi: 10.1016/j.ijantimicag.2004.03.010.
5
Mechanisms of resistance to daptomycin in Enterococcus faecium.粪肠球菌对达托霉素的耐药机制
Antimicrob Agents Chemother. 2008 Mar;52(3):1167-70. doi: 10.1128/AAC.00774-07. Epub 2008 Jan 7.
6
Multidrug-resistant Enterococcus faecium endocarditis treated with combination tigecycline and high-dose daptomycin.多药耐药粪肠球菌性心内膜炎采用替加环素联合高剂量达托霉素治疗。
Ann Pharmacother. 2009 Dec;43(12):2108-12. doi: 10.1345/aph.1M324. Epub 2009 Nov 3.
7
De novo daptomycin nonsusceptibility in a clinical isolate.临床分离株中达托霉素的从头非敏感性
J Clin Microbiol. 2006 Feb;44(2):673. doi: 10.1128/JCM.44.2.673.2006.
8
In vitro synergy of daptomycin plus rifampin against Enterococcus faecium resistant to both linezolid and vancomycin.达托霉素联合利福平对耐利奈唑胺和万古霉素的屎肠球菌的体外协同作用
Antimicrob Agents Chemother. 2005 Dec;49(12):5166-8. doi: 10.1128/AAC.49.12.5166-5168.2005.
9
In vitro activity of daptomycin against Staphylococcus aureus and vancomycin-resistant Enterococcus faecium isolates associated with skin and soft tissue infections: first results from India.达托霉素对与皮肤和软组织感染相关的金黄色葡萄球菌及耐万古霉素屎肠球菌分离株的体外活性：来自印度的初步结果
Diagn Microbiol Infect Dis. 2009 Oct;65(2):196-8. doi: 10.1016/j.diagmicrobio.2009.05.015.
10
Emergence of daptomycin-resistant Enterococcus faecium in a critically ill patient with postoperative intra-abdominal sepsis.一名患有术后腹腔内脓毒症的重症患者中出现了对达托霉素耐药的屎肠球菌。
Rev Esp Quimioter. 2015 Apr;28(2):109-10.

引用本文的文献

1
Emergence and Transmission of Daptomycin and Vancomycin-Resistant Enterococci Between Patients and Hospital Rooms.耐达霉素和万古霉素耐药肠球菌在患者和病房之间的出现和传播。
Clin Infect Dis. 2021 Dec 16;73(12):2306-2313. doi: 10.1093/cid/ciab001.
2
A mutation in the glycosyltransferase gene lafB causes daptomycin hypersusceptibility in Enterococcus faecium.糖苷转移酶基因 lafB 的突变导致屎肠球菌对达托霉素的敏感性增加。
J Antimicrob Chemother. 2020 Jan 1;75(1):36-45. doi: 10.1093/jac/dkz403.
3
Vancomycin-resistant enterococci with reduced daptomycin susceptibility in Singapore: prevalence and associated factors.
新加坡对达托霉素敏感性降低的耐万古霉素肠球菌：患病率及相关因素
Epidemiol Infect. 2016 Sep;144(12):2540-5. doi: 10.1017/S0950268816000923. Epub 2016 May 13.
4
Saponins increase susceptibility of vancomycin-resistant enterococci to antibiotic compounds.皂苷可增加耐万古霉素肠球菌对抗生素化合物的敏感性。
Eur J Microbiol Immunol (Bp). 2014 Dec;4(4):204-12. doi: 10.1556/EUJMI-D-14-00029. Epub 2014 Dec 16.
5
Whole-genome analysis of a daptomycin-susceptible enterococcus faecium strain and its daptomycin-resistant variant arising during therapy.万古霉素敏感屎肠球菌株及其治疗中出现的万古霉素耐药变异株的全基因组分析。
Antimicrob Agents Chemother. 2013 Jan;57(1):261-8. doi: 10.1128/AAC.01454-12. Epub 2012 Oct 31.
6
Daptomycin exposure precedes infection and/or colonization with daptomycin non-susceptible enterococcus.达托霉素暴露先于达托霉素不敏感肠球菌感染和/或定植。
Antimicrob Resist Infect Control. 2012 May 29;1(1):19. doi: 10.1186/2047-2994-1-19.
7
De novo daptomycin-nonsusceptible enterococcal infections.新生霉素不敏感肠球菌感染。
Emerg Infect Dis. 2012 Apr;18(4):674-6. doi: 10.3201/eid1804.110932.
8
Emergence of daptomycin-resistant VRE: experience of a single institution.万古霉素耐药肠球菌的出现：一家医疗机构的经验。
Infect Control Hosp Epidemiol. 2011 Apr;32(4):391-4. doi: 10.1086/659152.
9
Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians.对临床医生而言，达托霉素中介粪肠球菌：一种新出现的挑战。
Clin Infect Dis. 2011 Jan 15;52(2):228-34. doi: 10.1093/cid/ciq113.
10
A potential role for daptomycin in enterococcal infections: what is the evidence?达托霉素在肠球菌感染中的潜在作用：有何证据？
J Antimicrob Chemother. 2010 Jun;65(6):1126-36. doi: 10.1093/jac/dkq087. Epub 2010 Apr 2.